# Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG

> **NCT01978015** · PHASE4 · COMPLETED · sponsor: **University of Campinas, Brazil** · enrollment: 69 (actual)

## Conditions studied

- Uveitis, Anterior
- Cystoid Macular Edema

## Interventions

- **DRUG:** travoprost and timolol maleate fixed combination
- **DRUG:** latanoprost and maleate timolol fixed combination
- **DRUG:** bimatoprost and timolol maleate fixed combination
- **DRUG:** dextran and hypromellose

## Key facts

- **NCT ID:** NCT01978015
- **Lead sponsor:** University of Campinas, Brazil
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-07
- **Final completion:** 2013-01
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2013-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01978015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01978015, "Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01978015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*